Collagen hydrolysate for use in prevention and/or treatment of post intensive care syndrome (pics)
AssigneeRousselot B.V.
InventorsBarbara DE KLERK-ENGELS, Elien Monique GEVAERT, Praneeth Reddy KUNINTY, Janne PRAWITT, Nicolina VIRGILIO
Life of this patent
Estimating the term…
Abstract
The present invention relates to a use of collagen hydrolysate after intensive care unit (ICU) stay. The collagen hydrolysate improves the recovery and prevents and/or treats post intensive care syndrome (PICS) after ICU stay. The collagen hydrolysate is preferably administered as a supplement in the context of ICU stay and/or PICS. Collagen hydrolysate is generally-accepted to be safe and therefore can be taken as a preventive and long-term measure.
Claims20
Collagen hydrolysate for use in prevention and/or treatment of post-intensive care syndrome (PICS) after intensive care unit stay.
(canceled)
Use of collagen hydrolysate for improving the recovery after intensive care unit stay.
Use according toclaim 12, wherein the dosage regimen for collagen hydrolysate comprises administration of collagen hydrolysate starting within 3 weeks after intensive care unit stay.
20-22. (canceled)
Dependencies are inferred from the claim text.